Yu C - Search Results

1

Imaging diagnosis and efficacy monitoring by [⁸⁹Zr]Zr-DFO-KN035 immunoPET in patients with PD-L1-positive solid malignancies.

He H, Qi X, Fu H, Xu J, Zheng Q, Chen L, Zhang Y, Hua H, Xu W, Xu Z, Chen X, You Q, Lin J, Huang G, Mao Y, Yu C. He H, et al. Among authors: yu c. Theranostics. 2024 Jan 1;14(1):392-405. doi: 10.7150/thno.87243. eCollection 2024. Theranostics. 2024. PMID: 38164149 Free PMC article.

2

[The value of extra-lung lesions on ¹⁸F-FDG PET/CT in improving diagnosis of lung cancer].

Mi B, Wan W, Yu C, You X, Jiang F, You Q. Mi B, et al. Among authors: yu c. Zhongguo Fei Ai Za Zhi. 2012 Feb;15(2):78-83. doi: 10.3779/j.issn.1009-3419.2012.02.03. Zhongguo Fei Ai Za Zhi. 2012. PMID: 22336234 Free PMC article. Chinese.

3

Pilot Prospective Evaluation of (18)F-Alfatide II for Detection of Skeletal Metastases.

Mi B, Yu C, Pan D, Yang M, Wan W, Niu G, Chen X. Mi B, et al. Among authors: yu c. Theranostics. 2015 Jul 12;5(10):1115-21. doi: 10.7150/thno.12938. eCollection 2015. Theranostics. 2015. PMID: 26199649 Free PMC article. Clinical Trial.

4

Comparing the Differential Diagnostic Values of ¹⁸F-Alfatide II PET/CT between Tuberculosis and Lung Cancer Patients.

Du X, Zhang Y, Chen L, Mi B, You Q, Xu Y, Pan D, Wan W, Yang M, Yu C. Du X, et al. Among authors: yu c. Contrast Media Mol Imaging. 2018 Feb 19;2018:8194678. doi: 10.1155/2018/8194678. eCollection 2018. Contrast Media Mol Imaging. 2018. PMID: 29670497 Free PMC article. Clinical Trial.

5

Preclinical Evaluation of a Fluorine-18 Labeled Probe for the Detection of the Expression of PSMA Level in Cancer.

Guo Y, Gao D, Chen Y, Zhang Y, Chen L, Mao Y, Yu C, Qiu L, Lin J. Guo Y, et al. Among authors: yu c. ACS Omega. 2021 Mar 17;6(12):8279-8287. doi: 10.1021/acsomega.0c06353. eCollection 2021 Mar 30. ACS Omega. 2021. PMID: 33817487 Free PMC article.

6

Self-assembly of Fmoc-amino acids in capillary confined space forming a parallel ordered fiber network for application in vascularization.

Dong Q, Wang M, Wang A, Yu C, Bai S, Yin J, You Q. Dong Q, et al. Among authors: yu c. Biomater Sci. 2022 Mar 15;10(6):1470-1475. doi: 10.1039/d2bm00041e. Biomater Sci. 2022. PMID: 35170621

7

The efficacy and safety of Iodine-131-metaiodobenzylguanidine therapy in patients with neuroblastoma: a meta-analysis.

He H, Xu Q, Yu C. He H, et al. Among authors: yu c. BMC Cancer. 2022 Feb 28;22(1):216. doi: 10.1186/s12885-022-09329-2. BMC Cancer. 2022. PMID: 35227236 Free PMC article.

8

A fluorine-18 labeled radiotracer for PET imaging of γ-glutamyltranspeptidase in living subjects.

Gao D, Miao Y, Ye S, Lu C, Lv G, Li K, Yu C, Lin J, Qiu L. Gao D, et al. Among authors: yu c. RSC Adv. 2021 May 24;11(31):18738-18747. doi: 10.1039/d1ra01324f. eCollection 2021 May 24. RSC Adv. 2021. PMID: 35478654 Free PMC article.

9

EDB-FN targeted probes for the surgical navigation, radionuclide imaging, and therapy of thyroid cancer.

Li R, He H, Li X, Zheng X, Li Z, Zhang H, Ye J, Zhang W, Yu C, Feng G, Fan W. Li R, et al. Among authors: yu c. Eur J Nucl Med Mol Imaging. 2023 Jun;50(7):2100-2113. doi: 10.1007/s00259-023-06147-x. Epub 2023 Feb 18. Eur J Nucl Med Mol Imaging. 2023. PMID: 36807768

10

Development of a multifunctional platform for near-infrared imaging and targeted radionuclide therapy for tumors.

He H, Li K, Li H, Zhu S, Qin S, Mao Y, Lin J, Qiu L, Yu C. He H, et al. Among authors: yu c. Eur J Pharm Biopharm. 2023 Apr;185:107-115. doi: 10.1016/j.ejpb.2023.02.013. Epub 2023 Feb 27. Eur J Pharm Biopharm. 2023. PMID: 36858246

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23,734 results

Search Page

Filters